Quarterly report · Q2
4021.TEDINET S100QA13
Period2022-04-01 → 2022-09-30
Filed2023-02-21
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Amends S100PLK3.
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥109.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥208.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥91.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥28.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥21.3bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥32.0bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥53.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥22.3bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥32.0bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥22.3bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥23.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥38.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥16.3bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥24.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥16.4bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥280.2bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥279.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥247.4bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥60.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥71.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥219.4bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥208.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥197.4bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥43.9bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥34.7bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥43.9bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥28.4bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥43.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥41.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥33.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥9.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥12.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥29.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥27.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥31.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥167.74 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥69.58 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥271.88 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.94 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.18 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 77.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.1% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 63
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| Otherother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥5.3bn |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥7.2bn |
| Otherother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥100m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥51.3bn |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-09-30 | −¥14.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥36.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥2.3bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥35.7bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥31.2bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥12.1bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥19.8bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥13.7bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥6.0bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥42.0bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥34.0bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥8.0bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥13.9bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥3.2bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥3.2bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥47.6bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥36.5bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥11.1bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥160.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥123.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥36.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥30.5bn |
| Otherother segments | revenue | 2021-04-01 → 2021-09-30 | ¥10.4bn |
| Otherother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥4.4bn |
| Otherother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥6.0bn |
| Otherother segments | segment profit | 2021-04-01 → 2021-09-30 | −¥3m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥39.9bn |
| Reconciling Itemsreconciling | revenue external | 2021-04-01 → 2021-09-30 | −¥10.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥29.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥2.5bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥24.9bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥22.8bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥6.9bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥17.1bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥11.7bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥5.4bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥39.6bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥34.0bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥5.6bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥13.1bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥19m |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥36.4bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥25.7bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥10.8bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥131.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥101.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥29.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥23.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 576
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of long term prepaid expenses inv cf | CurrentYTDDuration | -49000000 | JPY |
| Other net inv cf | Prior1YTDDuration | 145000000 | JPY |
| Other net inv cf | CurrentYTDDuration | -3000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -6091000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -9633000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | -15893000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | -13623000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -276000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -276000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -8341000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -10208000000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | -48000000 | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | -105000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -7001000000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -5001000000 | JPY |
| Other net fin cf | Prior1YTDDuration | 0 | JPY |
| Other net fin cf | CurrentYTDDuration | -4000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -31560000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -29218000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | -121000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 1605000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -4008000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 6134000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 32380000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 34658000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1YTDDuration | － | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | CurrentYTDDuration | 3116000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 28371000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 43909000000 | JPY |
| Transportation expenses oerwy | Prior1YTDDuration | 504000000 | JPY |
| Transportation expenses oerwy | CurrentYTDDuration | 527000000 | JPY |
| Personnel expenditure sga | Prior1YTDDuration | 8272000000 | JPY |
| Personnel expenditure sga | CurrentYTDDuration | 8620000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 318000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 278000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 1507000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 1646000000 | JPY |
| Experiment cost sga | Prior1YTDDuration | 2460000000 | JPY |
| Experiment cost sga | CurrentYTDDuration | 2423000000 | JPY |
| Depreciation sga | Prior1YTDDuration | 1715000000 | JPY |
| Depreciation sga | CurrentYTDDuration | 1932000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00759-000ChemicalProductsReportableSegmentsMember | 11701000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00759-000FunctionalMaterialsReportableSegmentsMember | 33957000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00759-000AgriculturalChemicalProductsReportableSegmentsMember | 22800000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00759-000MedicinesReportableSegmentsMember | 3320000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00759-000WholesaleReportableSegmentsMember | 25656000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OtherReportableSegmentsMember | 4406000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 101843000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | -10035000000 | JPY |
| Revenues from external customers | Prior1YTDDuration | 91807000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |